Zoom Logo

Differentiated service delivery for HIV treatment (DSD ART) and the new WHO service delivery guidelines in the context of the Covid-19 pandemic - Shared screen with speaker view
Sarah Dixon (she/her) - FHI 360
22:02
Welcome and thank you for joining us. Please let us know your name and where you're joining us from?
Anthony Okoth
22:32
Hi, this is Ed Llewellyn. SC Technical Director at ARC
Anthony Okoth
22:43
Xoli Mabombo - Africa Resource Centre NPC (South Africa)
Anthony Okoth
22:55
Bronwyn Timm, Africa Resource Centre SA
Anthony Okoth
23:02
Please may I ask - will you be recording this session? I have a colleague who’s really benefit but wasn’t able to make it.
Mary Uloko
23:10
Hello everyone. Uloko Mary Caritas Nigeria
Anthony Okoth
23:19
Hi Everyone ! Ibnou from ARC West Africa
Moses Bateganya
23:21
I think we have a good number to start
Feliciano Cumaquela
23:48
Hello! Feliciano Cumaquela - DDDPP Manager, PSM Mozambique
Anthony Okoth
23:52
Hi I’m Rajeev Batohi from Africa Resource Centre SA
Helen Omuh
23:55
Hello everyone. Helen Omuh_IHVN Nigeria.
Advocate Dlamini
23:57
Dr Advocate Dlamini, Eswatini National AIDS Programme, Eswatini
Lirica Nishimoto - FHI 360
23:59
Yes, we are recording this session and the link will be sent to everyone who registered!
Anthony Okoth
24:03
Dr Bonface Fundafunda, Africa Resource Centre
Anthony Okoth
25:52
Anthony Okoth - East Africa Regional Director -Africa Resource Centre.
Ashley Greve
26:07
Ashley Greve, USAID/Office of HIV/AIDS
Anthony Okoth
26:08
Bonface Fundafunda, based in Lusaka, Zambia
Augustine Bangsi Fenangi
26:10
Bangsi Augustine-GGHLL(Cameroon)
Linda Muyumbu
26:36
Linda Muyumbu FHI 360 Strategic Information
Caterina Casalini
26:45
CCasalini, Sr Techn. Advisor for Clinical Services FHI360
Hally Mahler
26:46
Hally Mahler, FHI 360
Kevin Gibbons
26:55
Kevin Gibbons, Outreach Project Lead, Africa Resource Centre, Uganda. good day, everyone
Dennis Osiemo
26:56
Dennis Osiemo- USAID KEA
Temitope Kolade
27:01
Temitope Kolade, PCT Program Manager, IHVN, Nigeria
Anthony Okoth
27:02
Susan Njogo Supply Chain Technical Advisor-African Resource Centre-Kenya
Mpho Dimene
27:08
Mpho Dimene- EpICLesotho. Program officer
Olaitan Achor
27:14
Achor Olaitan, CIHP, Nigeria.
Eager Olyel
27:38
Love the poll! It really helps with engagement. Am HQ based in AFRO and the plan is to support the countries adopt the new guidelines.
christa fischer walker
27:41
Christa Fischer Walker, FHI 360 HQ
APIN Ekiti
27:51
Hello Everyone, Emmanuel Ndubuisi, APIN Nigeria
Jeremiah Lehloka
27:55
Jeremiah Lehloka, PACT, Lesotho
Jeremiah Lehloka
28:39
Jeremiah Lehloka, PACT , Lesotho
Hind satti
28:46
Hind Satti,FHI360
Christopher Akolo
29:04
Chris Akolo, FHI 360, Washington, DC
Helen Bygrave
29:41
Helen Bygrave ; Consultant with IAS DSD programme
Laura Muzart
29:57
Laura muzart, FHI 360 Eswatini
Sunday Inya
30:23
Hello everyone, Dr Sunday Inya, APIN Public Health Initiative, Benue. Nigeria
Nidze Guilovica
30:50
Hello everyone, Nidze Guilovica, USAID Mozambique
Rangsima Lolekha
31:04
Rangsima Lolekha, CDC Thailand
Pam Bachanas
31:15
Pam Bachanas, CDC Atlanta
Thomas Usha
31:32
Thomas Tersoo Usha, State Team Approach Lead, APIN Public Health Initiatives, Nigeria
farida Mushi
32:04
Farida Mushi, supply chain advisor USAID Namibia
Morkor Newman Owiredu
32:07
Morkor Newman Owiredu. WHO GVA
Nelli Bazarova
32:38
Nelli Barriere, IAS, Switzerland
Andrew Maranga
33:58
Andrew Maranga, EpiC/DDD Mozambique
Tolu Oladele
34:40
Oladele Tolulope, National Agency for the Control of AIDS, Nigeria
charity Alfredo
34:54
Charity Alfredo- CDC- Mozambique
Dr. Felix Iwuala
36:25
Greetings everyone. Dr. Felix Iwuala, ICHSSA 2 Project, Lagos Nigeria.
Karemangingo Saidi
44:03
Hello everyone, Dr Saidi Karemangingo, DSD Advisor, CQUIN Project, Bujumbura Burundi
Karemangingo Saidi
45:21
Hello everyone, Saidi Karemangingo,DSD Advisor,CQUIN, Burundi
Dr Anna Grimsrud (she/her)- IAS (the International AIDS Society)
48:28
Hi Everyone - don’t forget! We’d love to have your questions in the Q&A! Thanks.
Clarice Pinto (WHO HQ)
49:00
Please find the link to the Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update https://apps.who.int/iris/handle/10665/342899?locale-attribute=de&
Sarah Dixon (she/her) - FHI 360
50:32
Resources: https://www.fhi360.org/resource/meeting-targets-and-maintaining-epidemic-control-epic-decentralized-drug-distribution
Clarice Pinto (WHO HQ)
50:46
This is the link to the Updated Service Delivery guidelines released in March this yearhttps://apps.who.int/iris/bitstream/handle/10665/341052/9789240023581-eng.pdf
Jennifer Swanson
52:37
Hello, thank you for the presentations. Kindly please send the link to the dashboards from Anna's presentation. Thank you.
Clarice Pinto (WHO HQ)
54:18
Anna, there is a request for the link to the dashboards to be pasted in the chat.
Dr Anna Grimsrud (she/her)- IAS (the International AIDS Society)
54:28
The dashboards are here - http://bit.ly/DSDdashboards - you can also find them on www.differentiatedservicedelivery.org
Anthony Okoth
56:38
How do you manage or mitigate the high markup of pricing for the govt procured drugs or PEPFAR procured commodities when distributed in the private pharmacies, or who pays for the drugs? How are the drugs procured is it centralized? Are they access priced?How do you track distribution through private sector?
Simpson Tumwikirize
57:56
Drugs are from the ame
Anthony Okoth
58:22
In addition to the questions by Anthony, if the ARVs are free, is there a service fee charged and how much?
Simpson Tumwikirize
58:43
same source as for public HFs. Patients do not pay. Clinical partners facilitate the private pharmacies.
Dr Anna Grimsrud (she/her)- IAS (the International AIDS Society)
59:00
Thanks for the question - please put them directly in the Q&A rather than the chat function.
Dr. Felix Iwuala
01:08:31
Great presentations. Please share the slides.
Karemangingo Saidi
01:12:06
PODI as a community distribution point VS private pharmacies. What were limitations for PODI that made you decide to extend DDD to private sector. Is there any possibility for PLHIV to meet at pharmacy and share some care experiences?
SOMEDE
01:15:52
Hello to every one the materials been presented here are very useful kindly share after the meeting. Regards.
Clarice Pinto (WHO HQ)
01:18:24
Thank for this question. Materials and recordings from this sessions will be made available for all participants by email.
Karemangingo Saidi
01:19:46
interesting indeed, hope they are sending those presentations after the meeting
Clarice Pinto (WHO HQ)
01:27:27
Thank you and yes, all materials and recordings from this sessions will be made available for all participants by email.
Jean Georges RUKUBO
01:29:46
Thank you to all for presentations,
Karemangingo Saidi
01:29:54
great
Thomas Usha
01:32:24
Great Presentation, kindly share the link to previous presentation slides
Kent klindera
01:42:39
@Reshmie - thanks so much for the presentation; I also think there KPs who are health service providers--beyond being "lay workers" (e.g. Physicians; Nurses; etc.) who can play a critical role. I know a lot of KPs who have been motivated to continue their studies to be professionals (and something we need to be supportive by finding scholarship opportunities)….
Dr. Reshmie Ramautarsing - IHRI
01:46:41
@kent: completely agree, such a good point. we certainly need to support and empower communities to expand the roles they have in service delivery and engage health care workers from KP communities as much as possible
Sarah Dixon (she/her) - FHI 360
01:49:21
To register for the next session, click here: https://bit.ly/2UxnUt6
Kevin Gibbons
01:51:54
thank you all!
Baselisse Ndayisaba
01:51:54
Thank you very much
Carla Vazquez
01:51:55
thanks!